Alzheimer’s Disease: Driving Innovation with Compassion

On 18 September 2018, Quality Assistance held its second INNOVATION scientific congress at CEME in Charleroi. This edition focused on Alzheimer’s disease, a neurodegenerative condition affecting between 30 and 35 million people worldwide and continues to pose major challenges for science and society alike.

Alzheimer’s is more than memory loss. It gradually impacts thinking, behaviour, and the ability to perform everyday tasks—placing a heavy burden not only on patients but also on families and caregivers. Despite decades of research, effective treatments remain limited, and early diagnosis continues to be a major challenge.

The congress brought together leading voices from the pharmaceutical industry, academic research, and clinical practice.

The goal: to share the latest scientific insights, explore innovative therapeutic approaches, and foster collaboration across disciplines. Topics ranged from biomarkers and imaging technologies to the role of inflammation and protein misfolding in disease progression.

What made this event truly significant was its focus on translating science into real-world impact. The discussions emphasised the importance of patient-centric research, early intervention, and the need for regulatory frameworks that support innovation without compromising safety.

Our commitment to research and society

Beyond its scientific content, the congress also reflected our broader commitment to social responsibility and patient-centred innovation. By organising this event, we reaffirmed our role not only as a scientific partner but also as a contributor to the public health dialogue.

This commitment was echoed by Wilfried Nys, President of the Alzheimer Research Foundation, who emphasised the importance of collective support:

“To fulfil its mission, the Alzheimer Research Foundation relies entirely on donations, gift and legacies. The support of Quality Assistance represents a valuable contribution, adding to the generosity of our loyal donors and the efforts of public authorities in favour of scientific research in general.”

Alzheimer’s disease remains a challenge, but events like this congress show that progress is achievable when science is driven by collaboration, compassion, and a clear focus on human impact.

At Quality Assistance, we believe innovation must serve people. Through initiatives like these, we aim to support research that not only advances knowledge but also improves lives. Because behind every scientific breakthrough, there is a story of hope, resilience, and the shared pursuit of a better future.